AEMD: Hitting Key Milestones as Company Advances Clinical Study
By M. MarinNASDAQ: AEMDREAD THE FULL AEMD RESEARCH REPORTDSMB recommends AEMD progress clinical trial to the final third cohortAethlon Medical…
2,210$
-25,34%
Echtzeit-Aktienkurs Aethlon Medical Inc.
Bid:
Ask:
Nachrichten zur Aethlon Medical Inc. Aktie
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR
NASDAQ: AEMDLili Elston: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host,…
AEMD: Positive Takeaways From CEO Chat
By M. MarinNASDAQ: AEMDREAD THE FULL AEMD RESEARCH REPORTCompany’s current strategic focus is assessing the Hemopurifier in oncology…We participated in…
AEMD: Advancing Oncology Trial; Seeking to Simplify - Potentially Broaden – Device Application
By M. MarinNASDAQ:AEMDREAD THE FULL AEMD RESEARCH REPORTCohort 2 participants being treated, with queue building for patient participation in trialAethlon…
Aethlon Medical stock falls after $3.3M private placement By Investing.com
Aethlon Medical stock falls after $3.3M private placement…
Aethlon Medical präsentierte Quartalsergebnisse
Aethlon Medical stellte am 26.06.2025 die jüngste Quartalsbilanz zum am 31.03.2025 abgelaufenen Quartal vor.Es wurde ein Verlust je Aktie in…
Aethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call Transcript
…
Aethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call Transcript
…
Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript
…